James M.  Beck net worth and biography

James Beck Biography and Net Worth

James M. Beck has more than 30 years of healthcare services and distribution general management experience. Jim most recently served as Executive Chairman of Medical Specialties Distributors, a leading service solution provider serving the home infusion, home medical equipment, and oncology markets. He previously served as President and Chief Executive Officer of MSD. McKesson recently acquired medical Specialty Distributors (MSD) for $800 million. Prior to joining MSD, Jim held various executive and management positions with leading healthcare companies such as American Hospital Supply/Baxter Healthcare, AMSCO International, Spectrum Healthcare, and SHPS Health Management Solutions.

What is James M. Beck's net worth?

The estimated net worth of James M. Beck is at least $109,491.24 as of June 2nd, 2021. Mr. Beck owns 49,996 shares of KORU Medical Systems stock worth more than $109,491 as of April 28th. This net worth evaluation does not reflect any other investments that Mr. Beck may own. Learn More about James M. Beck's net worth.

How do I contact James M. Beck?

The corporate mailing address for Mr. Beck and other KORU Medical Systems executives is 24 CARPENTER RD, CHESTER NY, 10918. KORU Medical Systems can also be reached via phone at (845) 469-2042 and via email at [email protected]. Learn More on James M. Beck's contact information.

Has James M. Beck been buying or selling shares of KORU Medical Systems?

James M. Beck has not been actively trading shares of KORU Medical Systems within the last three months. Most recently, James M. Beck sold 21,275 shares of the business's stock in a transaction on Wednesday, June 2nd. The shares were sold at an average price of $4.63, for a transaction totalling $98,503.25. Following the completion of the sale, the director now directly owns 49,996 shares of the company's stock, valued at $231,481.48. Learn More on James M. Beck's trading history.

Who are KORU Medical Systems' active insiders?

KORU Medical Systems' insider roster includes James Beck (Director), and Joseph Manko, Jr. (Director). Learn More on KORU Medical Systems' active insiders.

Are insiders buying or selling shares of KORU Medical Systems?

In the last twelve months, KORU Medical Systems insiders bought shares 4 times. They purchased a total of 44,272 shares worth more than $114,828.16. The most recent insider tranaction occured on August, 21st when Director Joseph M Jr. Manko bought 10,000 shares worth more than $26,500.00. Insiders at KORU Medical Systems own 25.6% of the company. Learn More about insider trades at KORU Medical Systems.

Information on this page was last updated on 8/21/2023.

James M. Beck Insider Trading History at KORU Medical Systems

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/2/2021Sell21,275$4.63$98,503.2549,996View SEC Filing Icon  
See Full Table

James M. Beck Buying and Selling Activity at KORU Medical Systems

This chart shows James M Beck's buying and selling at KORU Medical Systems by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

KORU Medical Systems Company Overview

KORU Medical Systems logo
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
Read More

Today's Range

Now: $2.19
Low: $2.12
High: $2.22

50 Day Range

MA: $2.18
Low: $2.04
High: $2.49

2 Week Range

Now: $2.19
Low: $1.98
High: $4.48

Volume

91,205 shs

Average Volume

94,200 shs

Market Capitalization

$100.10 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.53